Abstract Title: currently loading...

information currently loading...

close
Loading ... please wait
timer Loading ... please wait

Free Paper Session 5: Vascular Diseases & Diabetic Retinopathy I

14:30 - 16:00 | 05 September | Room: Amphitheatre Havane

Back to Previous

14:30Assessment of hyperreflective foci following bevacizumab or dexamethasone according to duration of macular edema in branch retinal vein occlusion
J. Do Korea, Republic of
14:36A phase 3b, randomized study to compare three dosing regimens of intravitreal aflibercept for diabetic macular edema beyond the first year of treatment: primary outcomes of the violet study
J. Garweg Switzerland
14:42Aflibercept in macular oedema secondary to retinal vein occlusion refractory to previous bevacizumab or ranibizumab: 24 week outcomes
K. Spooner Australia
14:48Aflibercept in the real world – are the visual outcomes worse in patients with diabetic macula oedema who have had a cataract operation?
P. Scanlon United Kingdom
14:54Anatomical and durability outcomes from the BOULEVARD phase 2 trial of faricimab for DME
A. Seres Hungary
15:00Anti-VEGF in retinal vein occlusions: real data for long term outcomes
P. Corazza Italy
15:06Area-under-the-curve analysis of visual acuity following treatment with the 0.19 mg fluocinolone acetonide implant: Results from the Retro-IDEAL study
A. Augustin Germany
15:12Artificial intelligence algorithm that predicts diabetic retinopathy (DR) response to anti-VEGF treatment in patients via deep learning (DL)
Z. Haskova United States
15:18Artificial intelligence screening system for diabetic retinopathy: results from a pivotal multi-center prospective clinical trial
S. Sadda United States
15:24Baseline predictors for visual outcome in diabetic macular edema with good baseline visual acuity – obtain study
C. Busch Germany
15:30Clinical and OCT angiography features of post dengue fever retinal vasculopathy
S. Kabra India
15:36Clinical outcome of diabetic macular edema patients who lost to follow-up for more than 1 year after Anti-VEGF injections
J. Kim Korea, Republic of
15:42Comparing real-world outcomes of intravitreal anti-VEGF therapy for macular oedema secondary to central retinal vein occlusion between a Swiss and UK teaching hospital
S. Ah-Moye United Kingdom
15:48Real-world outcomes with dexamethasone intravitreal implant in the management of retinal vein occlusion in the UK
I. Pearce United Kingdom
Back to Previous

Want to find out more about EURETINA activities?

Contact us
© EURETINA All rights reserved